• Media type: E-Article
  • Title: A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib (GS-1101) in combination with bendamustine and rituximab for previously treated chronic lymphocytic leukemia (CLL)
  • Contributor: Eradat, Herbert Aaron; Robak, Tadeusz; Delgado, Julio; Schuh, Anna; Pristupa, Alexander S.; Omyla-Staszewska, Joanna; Barrientos, Jacqueline Claudia; Farber, Charles Michael; MacDonald, Donald; Jacob, Abraham; Sharman, Jeff Porter; Loscertales, Javier; Brown, Jennifer R.; Coiffier, Bertrand; Ghia, Paolo; Zelenetz, Andrew David; Evans, Shelley; Jahn, Thomas Michael; Hallek, Michael J.; Hillmen, Peter
  • imprint: American Society of Clinical Oncology (ASCO), 2014
  • Published in: Journal of Clinical Oncology
  • Language: English
  • DOI: 10.1200/jco.2014.32.15_suppl.tps7127
  • ISSN: 1527-7755; 0732-183X
  • Keywords: Cancer Research ; Oncology
  • Origination:
  • Footnote:
  • Access State: Open Access